DIRECTOR DEALINGS: Hikma Pharmaceuticals Founder Acquires Shares

Fri, 18th Oct 2013 16:24

LONDON (Alliance News) - Hikma Pharmaceuticals PLC Friday said its founder and non-executive chairman, Samih Darwazah, has disposed of 30,000 shares at a price of GBP11.00 per share.

The pharmaceutical company, which sprung out of Jordan in 1978, said Darwazah holds 13.4 million shares, or 6.76% of the company following Wednesday's transaction.

He owns 2.1 million shares directly and 11.3 million indirectly, through Darhold Limited.

Hikma shares Friday closed at 1,131.0 pence, up 1.5%.

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Related Shares

More News

3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

26 Apr 2024 13:36

UK dividends calendar - next 7 days

25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...

25 Apr 2024 10:15

Hikma Pharmaceuticals backs outlook after making strong start to 2024

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported an encouraging start to the year supported by all three business segments.

25 Apr 2024 08:01

Hikma delivers strong Q1, holds on to guidance

(Sharecast News) - Pharmaceuticals group Hikma said it has made a "strong and encouraging start" to 2024, with all three business segments performing ...